Afatinib CAS 850140-72-6
fatinib , Promotion Season Now in Store and Free Sample for Testing with Factory Price
Chemical Name: Afatinib
CAS No.:850140-72-6
Molecular Fomula:C24H25ClFN5O3
Molecular weight:485.94
Appearance:Yellow powder
Sample: Available

Afatinib: The Complete Guide
Request A Free Quote
Description of Afatinib
fatinib(INN; trade name Gilotrif in the US and Giotrif in Europe, previously Tomtovok and Tovok) is a drug approved in United States, Europe, Taiwan, Mexico, Chile and Japan as well as other countries for the first-line treatment of patients with distinct types of metastatic (EGFR mutation positive) non-small cell lung carcinoma (NSCLC), developed by Boehringer Ingelheim. It acts as an irreversible covalent inhibitor of the receptor tyrosine kinases epidermal growth factor receptor (EGFR) and erbB-2 (HER2).fatinib
Basic Info of Afatinib
Chemical Name | Afatinib |
Synonyms | BIBW 2992;2-Butenamide, N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-, (2E)-;(E)-Afatinib;Tovok;Afatinib freebase;Expand |
CAS No. | 850140-72-6 |
Molecular Formula | C24H25ClFN5O3 |
Molecular Weight | 485.93800 |
PSA | 88.61000 |
LogP | 4.53590 |
Properties
Appearance & Physical State | Off-White Solid |
Melting Point | 100 – 102 °C |
Numbering system
UNII | 41UD74L59M |
What is Afatinib?
- With the progress of science and technology and the development of society, chemical products have invariably permeated our daily lives, in medicine, food, cosmetics, electronics, industry, and other areas, becoming an essential part of our lives.
- One such product is fatinib which has developed particularly rapidly in recent years. Do you know about Afatinib?
- The official answer:Afatinib (afatinib) is a potent, irreversible dual inhibitor of epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 (HER2) tyrosine kinases.
What’s the application of Afatinib?
Like lapatinib and nalatinib, afatinib is a protein kinase inhibitor that also irreversibly inhibits human epidermal growth factor receptor 2 (Her2) and epidermal growth factor receptor (EGFR) kinases. Afatinib is not only useful against EGFR mutations targeted by first-generation tyrosine kinase inhibitors (TKI), such as erlotinib or giChemical bookfetinib, but also against less common mutations that are resistant to these drugs. However, it has no activity against T790M mutations that normally require third-generation drugs such as axitinib. Because it has additional activity against Her2, it is being studied against breast cancer as well as other EGFR and Her2-driven cancers.
Conclusion
Sincere to the customer and in good faith of quality is our forever followed motto. It’s the basement to be a human and do business. We take all responsibility for our products and service sincerely. We are a company integrating R&D, production, and sales. The design, research, and development of pharmaceutical intermediates include more than 330 kinds of pharmaceutical intermediates such as Anti-infectives, Cardiovascular and Cerebrovascular Systems, Digestive systems, Santi-tumor, Nervous systems, Geriatric Drugs, and Gynecological Drugs. At the same time, we have more than 4,000 factories in strategic cooperation with nearly 50,000 chemical products, so we can provide you with a one-stop purchasing service, which greatly saves customers’ procurement costs and time.

Hello, I’m Pew Ni, the chemical products one-stop solution expert.
Hi, I‘m Peter Ni, the founder of Sincere-Chem, I’ve been running a company in China that exporting chemicals, pharmaceuticals, and intermediates for over 70 countries now. And a range of 50,000 products with the best quality and competitive price to meet your different purchasing needs.
CEO Email: inquiry@sincerechemical.com
CEO Phone Number:
+86-188-6575 9396
CEO WhatsApp:
+86-188-6575 9396
Request A Free Quote
Keywords of Afatinib
fatinib,850140-72-6, buy fatinib, fatinibsupplier, purchase fatinib, fatinibcost, fatinibmanufacturer, order fatinib, high purity fatinib
WHY THEY SAY TO US








